Qiagen Q3 profit surges on COVID-19 testing demand

Written by on November 3, 2021

November 3, 2021

(Reuters) – U.S.-German genetic testing specialist Qiagen reported a surge in third-quarter profit on Wednesday, boosted by higher demand for its coronavirus tests amid a rise in infections due to the fast-spreading Delta variant.

Net income rose to $0.57 per share from $0.07 per share, a year earlier.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)

Current track